| Date | Title | Description | Source |
| 17.04.2024 | Parent Project Muscular Dystrophy Celebrates 30th Anniversar... | PPMD Together: Cincinnati Marks Three Decades of PPMD's Impact and Mayor's Proclamation
Honors Found... | salamancap... |
| 22.03.2024 | FDA Nod in Duchenne Helps Wider Swath of Patients With the R... | Duchenne muscular dystrophy has several approved drugs, including a gene therapy that provides child... | medcitynew... |
| 19.10.2023 | Royalty Pharma Announces Agreement to Purchase Up to $1.5 Bi... | - | globenewsw... |
| 07.09.2023 | Australian Patient Advocacy Organization Named a Recipient o... | - Grant funding will support Save our Sons Duchenne Foundation in developing a digital health app -
... | en.prnasia... |
| 17.05.2023 | PTC Posts Positive Phase 3 Data, But Comparison to BioMarin ... | A PTC Therapeutics drug in development for an inherited metabolic disorder has achieved the main goa... | medcitynew... |
| 08.02.2022 | PTC Therapeutics to Host Conference Call to Discuss Fourth Q... | SOUTH PLAINFIELD, N.J., Feb. 8, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 25.01.2022 | FDA Grants Evrysdi® Priority Review Based on Results From Tr... | SOUTH PLAINFIELD, N.J., Jan. 25, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 18.01.2022 | PTC Therapeutics Announces Launch of 8th Annual STRIVE™ Awar... | SOUTH PLAINFIELD, N.J., Jan. 18, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 14.01.2022 | PTC Therapeutics Reports Inducement Grants Under Nasdaq List... | SOUTH PLAINFIELD, N.J., Jan. 13, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 13.01.2022 | PTC Therapeutics Announces Launch of 2022 Global Talent Pipe... | SOUTH PLAINFIELD, N.J., Jan. 13, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 10.01.2022 | PTC Therapeutics Provides an Update on Commercial Progress a... | SOUTH PLAINFIELD, N.J., Jan. 10, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will pre... | marketscre... |
| 04.01.2022 | Waylivra™ Receives Innovative Drug Category Pricing to Treat... | SOUTH PLAINFIELD, N.J., Jan. 4, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 03.01.2022 | PTC Therapeutics to Present at the 40th Annual J.P. Morgan V... | SOUTH PLAINFIELD, N.J., Jan. 3, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 20.12.2021 | Oral Splicing Modifiers that Systemically Lower Huntington D... | SOUTH PLAINFIELD, N.J., Dec. 20, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 06.12.2021 | Evrysdi® Distinguished by Two Prestigious Awards for Outstan... | SOUTH PLAINFIELD, N.J., Dec. 6, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 03.12.2021 | PTC Therapeutics Reports Inducement Grants Under Nasdaq List... | SOUTH PLAINFIELD, N.J., Dec. 2, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 16.11.2021 | PTC Therapeutics to Participate at Upcoming Virtual Investor... | SOUTH PLAINFIELD, N.J., Nov. 16, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 28.10.2021 | PTC Therapeutics Provides a Corporate Update and Reports Thi... | SOUTH PLAINFIELD, N.J., Oct. 28, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 26.10.2021 | PTC Therapeutics to Participate at Upcoming Virtual Investor... | SOUTH PLAINFIELD, N.J., Oct. 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 25.10.2021 | PTC Therapeutics : Announces Expansion of Translarna™ Label ... | SOUTH PLAINFIELD, N.J., Oct. 25, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 18.10.2021 | HILA approves access to Translarna™ the first treatment appr... | HILA approves access to Translarna™ the first treatment approved for the underlying cause of childho... | news.cisio... |
| 14.10.2021 | PTC Therapeutics : to Host Conference Call to Discuss Third ... | SOUTH PLAINFIELD, N.J., Oct. 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 14.10.2021 | PTC Therapeutics : Celebrates Opening of Gene Therapy Manufa... | SOUTH PLAINFIELD, N.J., Oct. 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will hos... | marketscre... |
| 11.10.2021 | PTC Therapeutics : Tegsedi® Receives Innovative Drug Categor... | SOUTH PLAINFIELD, N.J., Oct. 11, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 23.08.2021 | PTC Therapeutics : Announces Waylivra™ Approval in Brazil as... | SOUTH PLAINFIELD, N.J., Aug. 23, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 23.08.2021 | PTC Therapeutics Announces Waylivra™ Approval in Brazil as F... | | prnewswire... |
| 29.07.2021 | PTC Therapeutics Provides a Corporate Update and Reports Sec... | | prnewswire... |
| 29.07.2021 | PTC Therapeutics : Provides a Corporate Update and Reports S... | SOUTH PLAINFIELD, N.J., July 29, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 26.05.2021 | PTC THERAPEUTICS, INC.
PTC Therapeutics : Announces Orphan ... | SOUTH PLAINFIELD, N.J., May 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 17.05.2021 | PTC Therapeutics : New Data Shows Devastating Impact of AADC... | SOUTH PLAINFIELD, N.J., May 17, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ann... | marketscre... |
| 04.05.2021 | PTC Therapeutics : Provides a Corporate Update and Reports F... | SOUTH PLAINFIELD, N.J., May 4, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today anno... | marketscre... |
| 01.05.2021 | PTC THERAPEUTICS, INC.
PTC Therapeutics : 2020 Annual Repor... | 2020 Annual Report
youHERE FOR
OUR PROMISE. Rare diseases, real strides to treat them-this is why we... | marketscre... |
| 14.04.2021 | PTC THERAPEUTICS, INC.
PTC Therapeutics : Launches the PTC ... | SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today i... | marketscre... |
| 01.04.2021 | PTC THERAPEUTICS, INC.
PTC Therapeutics : Announces Commerc... | SOUTH PLAINFIELD, N.J., April 1, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 30.03.2021 | PTC THERAPEUTICS, INC.
PTC Therapeutics : Announces the Eur... | SOUTH PLAINFIELD, N.J., March 30, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today a... | marketscre... |
| 09.03.2021 | Spinal Muscular Atrophy (SMA) Foundation and PTC Therapeutic... | NEW YORK and SOUTH PLAINFIELD, N.J., March 9, 2021 /PRNewswire/ -- The Spinal Muscular Atrophy (SMA)... | salamancap... |
| 09.03.2021 | Spinal Muscular Atrophy (SMA) Foundation and PTC Therapeutic... | NEW YORK and SOUTH PLAINFIELD, N.J., March 9, 2021 /PRNewswire/ -- The Spinal Muscular Atrophy (SMA)... | oaoa.com/n... |
| 26.02.2021 | PTC Therapeutics : Reports Fourth Quarter and Full Year 2020... | SOUTH PLAINFIELD, N.J., Feb. 25, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 25.02.2021 | PTC Therapeutics Reports Fourth Quarter and Full Year 2020 F... | SOUTH PLAINFIELD, N.J., Feb. 25, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | oaoa.com/n... |
| 24.02.2021 | Positive Data from FIREFISH Study of Evrysdi™ (risdiplam) in... | SOUTH PLAINFIELD, N.J., Feb. 24, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today a... | oaoa.com/n... |
| 14.01.2021 | PTC Therapeutics : Opens Applications for the Annual STRIVE ... | SOUTH PLAINFIELD, N.J., Jan. 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 14.01.2021 | PTC THERAPEUTICS, INC.
PTC Therapeutics : Opens Application... | SOUTH PLAINFIELD, N.J., Jan. 14, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today an... | marketscre... |
| 10.08.2020 | FDA approves Roche, PTC drug for spinal muscular atrophy | Shares of PTC were up less than 2% on the Nasdaq on Monday afternoon.
“We started looking for treatm... | medcitynew... |
| 17.06.2020 | PTC receives go-ahead from FDA to test cancer drug in Covid-... | The drug is in a 39-patient Phase Ib study in relapsed and refractory acute myeloid leukemia that op... | medcitynew... |
| 26.08.2019 | They rallied around ‘our boys’ as they pushed for a Duchenne... | Deb and Shawn Jenssen were used to frustration. Their kids had been turned away from studies. Doctor... | statnews.c... |
| 01.07.2019 | Updated: Lonza sets sights on expansion, buying Novar... | → Lonza Pharma & Biotech is expanding, buying up a Swiss facility Novartis has been us... | endpts.com... |
| 28.06.2019 | Unfazed by failure, PTC Therapeutics to appeal negat... | PTC Therapeutics’ bid to expand the approval of its Duchenne muscular dystrophy drug in Eu... | endpts.com... |
| 04.02.2019 | ‘We’re still waiting’: As cystic fibrosis drugs deliver new ... | CAMBRIDGE, Mass. — The tiny round one is vitamin K. There’s a gel cap (vitamin D), a two-tone capsul... | statnews.c... |
| 01.08.2017 | Is the FDA telegraphing a rejection for PTC Therapeutics’ DM... | The FDA’s once-raging internal debate over Sarepta Therapeutics has cooled, but a recently unearthed... | statnews.c... |
| 21.04.2017 | Another controversial drugmaker just left the industry's mos... | Reuters
President Donald Trump and PhRMA president Steve Ubl.
Marathon Pharmaceuticals is no longer ... | businessin... |
| 25.03.2017 | Knopp Biosciences Announces Election of Biotech Executive Sh... | Knopp Biosciences announced the appointment of Shane Kovacs to its Board of Managers. Kovacs joins t... | saturnpart... |
| 11.11.2016 | PTC shares rocket up as European regulators offer a t... | PTC Therapeutics CEO Stuart Peltz
A few days after warning investors of the rising uncerta... | endpts.com... |
| 17.10.2016 | PTC shares plunge anew after FDA slaps down Duchenne drug f... | PTC Therapeutics CEO Stuart Peltz
There will be no Lazarus-like rise from the dead for PTC Ther... | endpts.com... |
| 24.02.2016 | FDA rejects application for Duchenne drug, rattling investor... | Yet another company developing a drug for Duchenne muscular dystrophy suffered a setback as PTC Ther... | statnews.c... |
| 14.04.2015 | Duchenne Muscular Dystrophy market to shoot up 100-fold in f... | “These mutation-specific drugs are expected to have a high price point due to their novelty, efficac... | medcitynew... |
| 20.06.2013 | PTC Therapeutics joins the IPO scrum as more biotechs take a... | The nonsense mutation is the cause of Duchenne muscular dystrophy in about 13 percent of patients, o... | medcitynew... |
| 10.06.2013 | For new Rhode Island firm, peptides hold hope for disease-al... | Procaftor, Calista’s lead candidate, is designed to restore function to the CFTR transporter in the ... | medcitynew... |
| 07.03.2013 | PTC Therapeutics Completes $60M Financing | PTC Therapeutics, Inc., a South Plainfield, NJ-based biopharmaceutical company focused on the discov... | finsmes.co... |
| 23.07.2012 | PTC Therapeutics Completes $30M Financing | PTC Therapeutics, Inc. (PTC), a South Plainfield, NJ-based biopharmaceutical company focused on the ... | finsmes.co... |
| 23.07.2012 | Late-stage cystic fibrosis, muscular dystrophy drug raises $... | With cystic fibrosis the goal is to improve lung function and reduce pulmonary exacerbation. In a Ph... | medcitynew... |
| 14.06.2012 | Drug developer with phase 3 cystic fibrosis treatment raisin... | South Plainfield, New Jersey-based PTC Therapeutics‘ drug Ataluren was given orphan drug status by t... | medcitynew... |
| 16.04.2012 | Amicus Therapeutics names new CFO | Currently, Genzyme is the only other company that provides a drug for this disease since Shire dropp... | medcitynew... |
| 23.12.2011 | PTC Therapeutics Receives $5M Seeding Drug Discovery (SDD) A... | PTC Therapeutics, Inc., a South Plainfield, NJ-based biopharmaceutical company has received a $5m Se... | finsmes.co... |
| 22.12.2011 | PTC Therapeutics gets $5 million drug development award | Of the 1.7 million hospital-acquired bacterial infections that cause or contribute to nearly 100,000... | medcitynew... |
| 29.11.2011 | PTC Therapeutics licensing agreement with Roche valued up to... | PTC Therapeutics has agreed to a licensing deal with Swiss pharmaceutical firm Roche for its spinal ... | medcitynew... |
| 23.04.2007 | The boulevard of broken IPO dreams | Dollars may be sluicing into biotechnology via venture investments and acquisitions these days, but ... | venturebea... |
| - | Results from the Second Year of Evrysdi™ (risdiplam) Treatme... | SOUTH PLAINFIELD, N.J., March 16, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today a... | oaoa.com/n... |
| - | Drug developer with phase 3 cystic fibrosis treatment raisin... | A drug developer that recently reported positive phase 3 results for its cystic fibrosis treatment f... | medcitynew... |
| - | Amicus Therapeutics names new CFO | Amicus Therapeutics (NASDAQ:FOLD) has hired a biopharmaceutical industry veteran as chief financial ... | medcitynew... |
| - | PTC Therapeutics licensing agreement with Roche valued up to... | PTC Therapeutics has agreed to a licensing deal with Swiss pharmaceutical firm Roche for its spinal ... | medcitynew... |
| - | For new Rhode Island firm, peptides hold hope for disease-al... | It’s been nearly two-and-a-half decades since the gene associated with the inherited disease cystic ... | medcitynew... |
| - | FDA approves Roche, PTC drug for spinal muscular atrophy | The Food and Drug Administration has approved the latest entrant into the market for drugs to treat ... | medcitynew... |
| - | CHMP Adopts Positive Opinion for Evrysdi™ for the Treatment ... | SOUTH PLAINFIELD, N.J., Feb. 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today a... | oaoa.com/n... |
| - | Late-stage cystic fibrosis, muscular dystrophy drug raises $... | A biopharmaceutical company with a cystic fibrosis drug in late-stage development has raised $30 mil... | medcitynew... |
| - | Duchenne Muscular Dystrophy market to shoot up 100-fold in f... | As a whole host of new Duchenne Muscular Dystrophy therapies mature down the regulatory pathway, the... | medcitynew... |
| - | PTC receives go-ahead from FDA to test cancer drug in Covid-... | Drugs in development for Covid-19 generally fall into two categories: antivirals that go after the S... | medcitynew... |
| - | PTC Therapeutics joins the IPO scrum as more biotechs take a... | It may not be the most complimentary assessment of a biotech’s initial public offering to say that i... | medcitynew... |
| - | PTC Therapeutics gets $5 million drug development award | PTC Therapeutics has received a $5 million Seeding Drug Discovery award from UK charity Wellcome Tru... | medcitynew... |
| - | PTC Presents Results from a Real-World Study of Steroid Swit... | SOUTH PLAINFIELD, N.J., March 15, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today a... | oaoa.com/n... |